GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis.

Speca S, Dubuquoy C, Rousseaux C, Chavatte P, Desreumaux P, Spagnolo P.

DOI: 10.1038/s41423-020-0394-y
Published: 2020-03-12
Container: Cell Mol Immunol
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1038/s41423-020-0394-y,
  title = {GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis.},
  author = {Speca S and  Dubuquoy C and  Rousseaux C and  Chavatte P and  Desreumaux P and  Spagnolo P.},
  year = {2020},
  journal = {Cell Mol Immunol},
  doi = {10.1038/s41423-020-0394-y},
  url = {https://doi.org/10.1038/s41423-020-0394-y}
}

RIS

TY  - JOUR
TI  - GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis.
AU  - Speca S
AU  -  Dubuquoy C
AU  -  Rousseaux C
AU  -  Chavatte P
AU  -  Desreumaux P
AU  -  Spagnolo P.
PY  - 2020
JO  - Cell Mol Immunol
DO  - 10.1038/s41423-020-0394-y
UR  - https://doi.org/10.1038/s41423-020-0394-y
ER  -

APA

S, S., C, D., C, R., P, C., P, D., & P., S. (2020). GED-0507 is a novel potential antifibrotic treatment option for pulmonary fibrosis.. Cell Mol Immunol. https://doi.org/10.1038/s41423-020-0394-y

Source records

europe-pmc · retrieved 2026-09-27T02:24:15.597Z
hal · retrieved 2026-09-27T02:24:15.611Z